Gilead Adds Jounce to its Long List of Oncology Partnerships
On 1st September, Gilead Sciences announced a strategic collaboration with Jounce Therapeutics to grab an exclusive license agreement for a novel immunotherapy program. By Ruchi Jhonsa, Ph.D. Founded with a …
Read More